Afshan Masood

2.7k total citations · 1 hit paper
68 papers, 1.9k citations indexed

About

Afshan Masood is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Afshan Masood has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Afshan Masood's work include Metabolism, Diabetes, and Cancer (12 papers), Metabolomics and Mass Spectrometry Studies (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Afshan Masood is often cited by papers focused on Metabolism, Diabetes, and Cancer (12 papers), Metabolomics and Mass Spectrometry Studies (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Afshan Masood collaborates with scholars based in Saudi Arabia, Canada and Jordan. Afshan Masood's co-authors include Aishah Ekhzaimy, Meena Kishore Sakharkar, Shariq I. Sherwani, Haseeb A. Khan, Assim A. Alfadda, Hicham Benabdelkamel, Anas M. Abdel Rahman, Ibrahim O. Alanazi, Mysoon M. Al‐Ansari and Waleed Alghamdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Afshan Masood

61 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients

2016 841 citations Aishah Ekhzaimy, Afshan Masood et al. profile →

Peers

Countries citing papers authored by Afshan Masood

Since Specialization

Citations

This map shows the geographic impact of Afshan Masood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afshan Masood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afshan Masood more than expected).

Fields of papers citing papers by Afshan Masood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afshan Masood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afshan Masood. The network helps show where Afshan Masood may publish in the future.

Co-authorship network of co-authors of Afshan Masood

This figure shows the co-authorship network connecting the top 25 collaborators of Afshan Masood. A scholar is included among the top collaborators of Afshan Masood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afshan Masood. Afshan Masood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Untargeted metabolomics reveals immune-metabolic signatures in established cases of rheumatoid arthritis 2026 ·Frontiers in Molecular Biosciences ·Afshan Masood, (unknown), (unknown), (unknown), Amal Jaafar, Hicham Benabdelkamel, Assim A. Alfadda, (unknown), (unknown), Mohamed Siaj, (unknown)	0
2	Proteomic Profiling of Endometrial Cancer Tissues Reveals Differential Expression of Proteomes in Obese Versus Non-Obese Patients 2026 ·Cells ·Khalid Akkour, (unknown), Assim A. Alfadda, (unknown), Afshan Masood, Salini Scaria Joy, (unknown), (unknown), (unknown), H Alhalal, (unknown), Rukhsana Gul, Hicham Benabdelkamel	0
3	Tissue-Based Metabolomic Profiling of Endometrial Cancer and Hyperplasia 2025 ·Metabolites ·Khalid Akkour, Afshan Masood, (unknown), (unknown), Assim A. Alfadda, Salini Scaria Joy, (unknown), H Alhalal, Maria Arafah, (unknown), (unknown), Anas M. Abdel Rahman, Hicham Benabdelkamel	0
4	Assessing the protective effects of nanoceria on angiotensin II-induced cardiac injury in H9c2 cardiomyoblasts using proteomic analysis 2025 ·Journal of Pharmaceutical and Biomedical Analysis ·Rukhsana Gul, Hicham Benabdelkamel, Mushtaq Ahmad Dar, Afshan Masood, Meshail Okla, Ibrahim O. Alanazi, Assim A. Alfadda	0
5	Proteomic Profiling Reveals Novel Molecular Insights into Dysregulated Proteins in Established Cases of Rheumatoid Arthritis 2025 ·Proteomes ·Afshan Masood, Hicham Benabdelkamel, Assim A. Alfadda, Abdurhman S Al-Arfaj, (unknown), Salini Scaria Joy, (unknown), Anas M. Abdel Rahman, Mohamed Siaj	2
6	Untargeted metabolomics reveals the impact of Liraglutide treatment on metabolome profiling and metabolic pathways in type-2 diabetes mellitus 2024 ·Saudi Pharmaceutical Journal ·Hicham Benabdelkamel, (unknown), (unknown), Afshan Masood, Assim A. Alfadda, Anas M. Abdel Rahman	5
7	Label-Free Quantitative Proteomics Analysis of Nasal Lavage Fluid in Chronic Rhinosinusitis with Nasal Polyposis 2024 ·Biology ·(unknown), Afshan Masood, Assim A. Alfadda, Salini Scaria Joy, (unknown), (unknown), (unknown), (unknown), Saad Alsaleh, Hicham Benabdelkamel	1
8	Metabolomic Profiling of Blood Plasma in Females with Hyperplasia and Endometrial Cancer 2024 ·Metabolites ·Hicham Benabdelkamel, (unknown), Khalid Akkour, (unknown), Assim A. Alfadda, Afshan Masood, Salini Scaria Joy, H Alhalal, (unknown), Maria Arafah, (unknown), Anas M. Abdel Rahman	4
9	Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin 2023 ·Pharmaceuticals ·(unknown), Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, (unknown), Ibrahim O. Alanazi, (unknown), Anas M. Abdel Rahman, Hicham Benabdelkamel	3
10	Metabolomics in diabetes mellitus: clinical insight 2023 ·Expert Review of Proteomics ·Shereen M. Aleidi, (unknown), Afshan Masood, Anas M. Abdel Rahman	3
11	Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment 2023 ·Current Issues in Molecular Biology ·Mohamed Rafiullah, Hicham Benabdelkamel, Afshan Masood, Aishah Ekhzaimy, (unknown), Salini Scaria Joy, Assim A. Alfadda	9
12	Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells 2023 ·International Journal of Molecular Sciences ·(unknown), Mysoon M. Al‐Ansari, Assim A. Alfadda, (unknown), Afshan Masood, Anas M. Abdel Rahman, Hicham Benabdelkamel	4
13	Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients 2023 ·International Journal of Molecular Sciences ·Minnie Jacob, Afshan Masood, Anas M. Abdel Rahman	2
14	Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis 2022 ·International Journal of Molecular Sciences ·Mysoon M. Al‐Ansari, Shereen M. Aleidi, Afshan Masood, (unknown), (unknown), (unknown), (unknown), Hicham Benabdelkamel, Anas M. Abdel Rahman	19
15	Identification of Protein Changes in the Urine of Hypothyroid Patients Treated with Thyroxine Using Proteomics Approach 2021 ·ACS Omega ·Afshan Masood, Hicham Benabdelkamel, Anwar A. Jammah, Aishah Ekhzaimy, Assim A. Alfadda	7
16	Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients 2021 ·Molecules ·Fawaz Alasmari, Sary Alsanea, Assim A. Alfadda, Ibrahim O. Alanazi, (unknown), Afshan Masood, Faleh Alqahtani, Omer I. Fantoukh, Abdullah F. Alasmari, Hicham Benabdelkamel	3
17	A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients 2021 ·Metabolites ·Shereen M. Aleidi, (unknown), (unknown), Afshan Masood, Hicham Benabdelkamel, Mysoon M. Al‐Ansari, Anas M. Abdel Rahman	33
18	Insecticidal, antimicrobial and antioxidant activities of essential oil from Lavandula latifolia L. and its deterrent effects on Euphoria leucographa 2021 ·Industrial Crops and Products ·Mysoon M. Al‐Ansari, (unknown), (unknown), (unknown), Afshan Masood, Ponnuswamy Vijayaraghavan, Anas M. Abdel Rahman, Ki Choon Choi	28
19	Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis 2020 ·International Journal of Molecular Sciences ·Hicham Benabdelkamel, (unknown), Meshail Okla, Afshan Masood, (unknown), Ibrahim O. Alanazi, Assim A. Alfadda, Imran Nizami, Majed Dasouki, Anas M. Abdel Rahman	14
20	Proteomic analysis of mature adipo cytes from obese patients in relation to aging 2013 ·Experimental Gerontology ·Assim A. Alfadda, Hicham Benabdelkamel, Afshan Masood, Amr Soliman Moustafa, Reem M. Sallam, (unknown), (unknown)	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact